These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27885695)

  • 21. Pharmacokinetics of ceftiofur hydrochloride in pigs infected with porcine reproductive and respiratory syndrome virus.
    Tantituvanont A; Yimprasert W; Werawatganone P; Nilubol D
    J Antimicrob Chemother; 2009 Feb; 63(2):369-73. PubMed ID: 19073620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of wild-type PRRSV detection patterns with mortality of MLV-vaccinated growing pig groups.
    Moura CAA; Philips R; Silva GS; Ramirez A; Gauger PC; Holtkamp DJ; Linhares DCL
    Prev Vet Med; 2021 Apr; 189():105270. PubMed ID: 33550121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
    Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
    Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive immunomodulatory effects of heterologous DNA vaccine- modified live vaccine, prime-boost immunization, against the highly-pathogenic PRRSV infection.
    Sirisereewan C; Nedumpun T; Kesdangsakonwut S; Woonwong Y; Kedkovid R; Arunorat J; Thanawongnuwech R; Suradhat S
    Vet Immunol Immunopathol; 2017 Jan; 183():7-15. PubMed ID: 28063479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination with a porcine reproductive and respiratory syndrome virus vaccine at 1-day-old improved growth performance of piglets under field conditions.
    Jeong J; Kim S; Park KH; Kang I; Park SJ; Yang S; Oh T; Chae C
    Vet Microbiol; 2018 Feb; 214():113-124. PubMed ID: 29408022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
    Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
    Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
    Fontanella E; Ma Z; Zhang Y; de Castro AM; Shen H; Halbur PG; Opriessnig T
    Vaccine; 2017 Jan; 35(1):125-131. PubMed ID: 27876202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Description of changes of key performance indicators and PRRSV shedding over time in a naïve breeding herd following a PRRS MLV exposure.
    Trevisan G; Johnson C; Benjamin N; Bradner L; Linhares DCL
    Transbound Emerg Dis; 2021 Nov; 68(6):3230-3235. PubMed ID: 34553831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a modified-live virus vaccine against porcine reproductive and respiratory syndrome in boars.
    Christopher-Hennings J; Nelson EA; Nelson JK; Benfield DA
    Am J Vet Res; 1997 Jan; 58(1):40-5. PubMed ID: 8989494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
    Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
    Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of commercial type 1 and type 2 PRRSV vaccines against heterologous dual challenge.
    Choi K; Park C; Jeong J; Kang I; Park SJ; Chae C
    Vet Rec; 2016 Mar; 178(12):291. PubMed ID: 26864027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of ampicillin, ceftiofur, attenuated live PRRSV vaccine, and reduced dose Streptococcus suis exposure on disease associated with PRRSV and S. suis coinfection.
    Schmitt CS; Halbur PG; Roth JA; Kinyon JM; Kasorndorkbua C; Thacker B
    Vet Microbiol; 2001 Jan; 78(1):29-37. PubMed ID: 11118739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of different vaccination schedules for sustaining the immune response against porcine reproductive and respiratory syndrome virus.
    Díaz I; Gimeno M; Callén A; Pujols J; López S; Charreyre C; Joisel F; Mateu E
    Vet J; 2013 Aug; 197(2):438-44. PubMed ID: 23499541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dietary threonine and tryptophan supplementation on growing pigs induced by porcine respiratory and reproductive syndrome vaccination.
    Xu S; Shen J; Fang Z; Zhao Y; Lin Y; Che L; Wu D
    Arch Anim Nutr; 2014; 68(5):385-97. PubMed ID: 25115344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
    Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
    Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
    Linhares DC; Cano JP; Wetzell T; Nerem J; Torremorell M; Dee SA
    Vaccine; 2012 Jan; 30(2):407-13. PubMed ID: 22063389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.